ABSTRACT
INTRODUCTION
Cancer of the cervix is the 3 rd most common cancer in women worldwide. An estimated 530,000 women across the world were diagnosed with cervical cancer worldwide in the year 2008. The developing countries carry the biggest burden of cervical cancer, with more than eight out of ten (86%) cases being diagnosed in 2008 (Ferley et al., 2008) . It is the most common female genital cancer constituting a major cause of mortality among Nigerian females in their most productive years (Mohammed et al., 2006) . The World Health Organization estimates the age-standardized incidence rate of cervical cancer for Nigeria to be 33 per 100,000 women. Cervical cancer mortality rate for the country (22.9 deaths per 100,000 women) ranks 10 th among countries in the world (Boyle and Levin, 2008 Considering the potential contribution of early detection and treatment of SIL towards control and prevention of cervical cancer, a pioneer study on the prevalence of SIL in Jalingo is of utmost importance. The aim of this study is to determine the prevalence of squamous intraepithelial lesions (SIL) of the cervix among women of reproductive age in Jalingo, Nigeria.
MATERIALS AND METHODS
Women attending Specialist Hospital Jalingo for routine gynaecological conditions were invited to participate in a cervical cancer screening study. All sexually active women between the ages of 16-45 years who provided informed consent were included in the study. Ethics approval was obtained from Research Ethics Committee of the hospital. All participants were screened with conventional cervical cytology (Pap smear). Smears were made from cervical specimens, fixed in ethanol and stained by the Papanicolaou technique. Cytopathology reports were based on the Bethesda classification system (Diane and Ritu, 2004 (Table I) . Out of the participants with negative report, 18.9% had inflammatory smears. The age specific prevalence rate (21%) was highest among the age group 36-40 years (Table II) .
DISCUSSION
The percentage of women positive for SIL (16.1%) in Jalingo is high compared to figures from similar studies in Nigeria. Studies from Abuja, Kano and Enugu revealed prevalence of 6.8%, 10.3% and 12.2% respectively (Pimentel et al., 2013; Yakasai et al., 2012; Chukwuali et al., 2003) . The higher prevalence in this study may likely be related to the relatively less urban nature of Jalingo. Screening services in Jalingo are almost nonexistent and that may hinder prompt identification and management of squamous intraepithelial lesions and that can lead to the high figures as seen in our study. Additionally, Abuja, Kano and Enugu are economically prosperous environments compared to Jalingo, and there is well documented association between low socioeconomic status and high prevalence of HPV infection (Bosch et al., 2002; Richter et al., 2013) . This prevalence is however, comparable to those reported in rural communities in South Africa (17.3%) (Teixeira et al., 2012) and Brazil (23%) (Franco et al., 1999) . Among the subtypes of SIL, LSIL (68.3% of all SIL) predominates while HSIL constitutes 29.3% and ASC-US constitutes 2.4%. This contrasts with reports of the study in Kano where majority of positive patients (63.2%) had HSIL. This probably just represents difference in the specific time the condition is detected within the natural history of SIL as over 80% of HSIL are known to arise from LSIL (Obure et al., 2009) . The Kano report is still surprising because not all LSIL progress to HSIL and the differential is difficult to explain. The highest age specific SIL prevalence figure for the age group 36-40 in our study is similar to that reported in Tanzania. HPV infection has a long latent period (Obure et al., 2009 ) and that age group may represent the period of manifestation of lesions resulting from HPV infections contracted from earlier years of sexual activities (Obure et al., 2009 ).
CONCLUSION
The prevalence of squamous intraepithelial lesions is high and there is the need for intervention in terms of health education, vaccination, mass screening and management of abnormal smears. 
